A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.

NCT02839135 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Motion Sickness

Interventions

DRUG: Reformulated scopolamine patch
DRUG: Marketed scopolamine patch

Sponsor

GlaxoSmithKline